CD200

CD200

CD200 분자 정보

Molecule Name
OX-2 membrane glycoprotein
분자 별명
CD200,MOX1,MOX2,MRC,OX-2,My033
Drug Development Progress
임상 약물 수1
시판 약물 수0
최고 연구 개발 단계Phase 2 Clinical
표적 별명
My033,CD200,CD200 Antigen,Antigen Identified By Monoclonal Antibody MRC OX-2,MOX1,OX-2 Membrane Glycoprotein,OX-2,MRC,CD200 Molecule,MOX2
분자 배경
CD200 is also known as OX-2 membrane glycoprotein (OX-2), is a type-1 membrane glycoprotein, which contains two immunoglobulin domains (1 Ig-like C2-type (immunoglobulin-like) domain and Ig-like V-type (immunoglobulin-like) domain), and thus belongs to the immunoglobulin superfamily. CD200 / OX-2 is widely expressed in multiple cell types. CD200 interacts with a structurally related receptor (CD200R) expressed mainly on myeloid cells and is involved in regulation of macrophage and mast cell function. OX-2 / CD200 and CD200R associate via their respective N-terminal Ig-like domains. CD200 also plays an important role in prevention of graft rejection, autoimmune diseases and spontaneous abortion.

CD200 제품 목록

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
P-00623ME-00610; P-006; 23ME’610Phase 2 Clinical23andme Inc
Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Fallopian Tube Neoplasms; Microsatellite instability-high cancer; Neuroendocrine Tumors; Peritoneal Neoplasms; Small Cell Lung Carcinoma; Solid tumours
상세